Successful liver transplant for unresectable hepatoblastoma

Journal of Pediatric Surgery

Volumn 42, Issue 1, 2007, Pages 184-187

  Casas Melley, Adela T ^a   Malatack, Jeffrey ^a   Consolini, Deborah ^a   Mann, Keith ^a   Raab, Christopher ^a   Flynn, Louise ^a   Woolfrey, Pamela ^a   Menendez, Jerome ^a   Dunn, Stephen P ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Alpha fetoprotein; Hepatoblastoma; Liver transplant; Unresectable

Indexed keywords

ALPHA FETOPROTEIN; AMIFOSTINE; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; IRINOTECAN; TOPOTECAN; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CARDIOTOXICITY; CAVA VEIN; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEPATOBLASTOMA; HUMAN; INOPERABLE CANCER; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUROTOXICITY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT OUTCOME; VEIN SURGERY;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 33845933421     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2006.09.017     Document Type: Article

References (11)

1. Ortego J.A., Douglas E.C., Feusner J.H., et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18 (2000) 2665-2675
2. Vos A. Primary liver tumors in children. Eur J Surg Oncol 21 (1995) 101-105
3. Tiao G.M., Bobey N., Allen S., et al. The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation. J Pediatr 146 2 (2005) 204-211
4. Reynolds M., Douglas E.C., Finegold D.M., et al. Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg 27 (1992) 1080-1083
5. Reyes J.D., Carr B., Dvorchik I., et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 136 6 (2000) 795-804
6. Pimpalwar A.P., Sharif K., Ramani P., et al. Strategy for hepatoblastoma management: transplant versus nontransplant surgery. J Pediatr Surg 37 2 (2002) 240-245
7. Cillo U., Ciarleglio F.A., Bassanello M., et al. Liver transplantation for the management of hepatoblastoma. Transplant Proc 35 8 (2003) 2983-2985
8. Czauderna P., Otte J.B., Aronson D.C., et al. Guidelines for surgical treatment of hepatoblastoma in the modern era-recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 41 7 (2005) 1031-1036
9. Otte J.B., deVille de Goyet J., and Reding R. Liver transplantation for hepatoblastoma: indications and contraindications in the modern era. Pediatr Transplant 9 5 (2005) 557-565
10. UNOS data, Pediatric Transplantation Committee Meeting, Scientific Registry of Transplant Recipients, May 2002.
11. Van Tornout J.M., Buckley J.D., Quinn J.J., et al. Timing and magnitude of decline in alpha-fetoprotein levels with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group. J Clin Oncol 15 (1997) 1190-1197